Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health plc (PRTC) Cash & Current Investments (2019 - 2024)

PureTech Health (PRTC) has disclosed Cash & Current Investments for 3 consecutive years, with $350.1 million as the latest value for Q4 2022.

  • On a quarterly basis, Cash & Current Investments fell 24.83% to $350.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $350.1 million, a 24.83% decrease, with the full-year FY2022 number at $350.1 million, down 24.83% from a year prior.
  • Cash & Current Investments was $350.1 million for Q4 2022 at PureTech Health, down from $465.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $465.7 million in Q4 2021 to a low of $350.1 million in Q4 2022.
  • A 3-year average of $406.6 million and a median of $403.9 million in 2020 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: increased 15.31% in 2021, then decreased 24.83% in 2022.
  • PureTech Health's Cash & Current Investments stood at $403.9 million in 2020, then increased by 15.31% to $465.7 million in 2021, then fell by 24.83% to $350.1 million in 2022.
  • Per Business Quant, the three most recent readings for PRTC's Cash & Current Investments are $350.1 million (Q4 2022), $465.7 million (Q4 2021), and $403.9 million (Q4 2020).